C
2.01
0.06 (3.08%)
前收盘价格 | 1.95 |
收盘价格 | 1.96 |
成交量 | 3,029,167 |
平均成交量 (3个月) | 1,077,388 |
市值 | 768,412,992 |
价格/销量 (P/S) | 6.93 |
股市价格/股市净资产 (P/B) | 0.710 |
52周波幅 | |
利润日期 | 26 Feb 2025 - 3 Mar 2025 |
营业毛利率 | -56.43% |
营业利益率 (TTM) | -54.08% |
稀释每股收益 (EPS TTM) | -0.120 |
季度收入增长率 (YOY) | 46.00% |
总债务/股东权益 (D/E MRQ) | 0.19% |
流动比率 (MRQ) | 28.29 |
营业现金流 (OCF TTM) | 16.17 M |
杠杆自由现金流 (LFCF TTM) | -30.52 M |
资产报酬率 (ROA TTM) | -3.73% |
股东权益报酬率 (ROE TTM) | -5.29% |
市场趋势
短期 | 中期 | ||
行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
股票 | Cronos Group Inc. Common Share | 混合的 | 看涨 |
AIStockmoo 评分
0.8
分析师共识 | NA |
内部交易活动 | NA |
价格波动 | 0.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 2.0 |
平均 | 0.83 |
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. |
|
部门 | Healthcare |
行业 | Drug Manufacturers - Specialty & Generic |
投资方式 | Small Growth |
内部持股比例 | 46.40% |
机构持股比例 | 15.62% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Timelo Investment Management Inc. | 30 Sep 2024 | 754,803 |
该时间范围内无数据。
该时间范围内无数据。
日期 | 类型 | 细节 |
---|---|---|
12 Nov 2024 | 公告 | Cronos Group Reports 2024 Third Quarter Results |
29 Oct 2024 | 公告 | Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合